4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000053
Director sold 786 shares at an average $20.92 ($16,439)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Pauls Matthew · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-02 | Sale : show line 1 in the form 10b5-1 | −415 | $20.52 | $8,514 | 15,521 | D |
| 2026-04-02 | Sale : show line 2 in the form 10b5-1 | −371 | $21.36 | $7,926 | 15,150 | D |
| Open-market sales · 786 sh · avg $20.92 · $16,439 | ||||||
Loading xslF345X06/wk-form4_1775509361.xml…